Cargando…

Active surveillance in intermediate risk prostate cancer: is it safe?

Detalles Bibliográficos
Autores principales: Krishnananthan, Nishanth, Lawrentschuk, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920556/
https://www.ncbi.nlm.nih.gov/pubmed/27286102
http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.03.04
_version_ 1782439415699734528
author Krishnananthan, Nishanth
Lawrentschuk, Nathan
author_facet Krishnananthan, Nishanth
Lawrentschuk, Nathan
author_sort Krishnananthan, Nishanth
collection PubMed
description
format Online
Article
Text
id pubmed-4920556
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Sociedade Brasileira de Urologia
record_format MEDLINE/PubMed
spelling pubmed-49205562016-06-27 Active surveillance in intermediate risk prostate cancer: is it safe? Krishnananthan, Nishanth Lawrentschuk, Nathan Int Braz J Urol Difference of Opinion Sociedade Brasileira de Urologia 2016 /pmc/articles/PMC4920556/ /pubmed/27286102 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.03.04 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Difference of Opinion
Krishnananthan, Nishanth
Lawrentschuk, Nathan
Active surveillance in intermediate risk prostate cancer: is it safe?
title Active surveillance in intermediate risk prostate cancer: is it safe?
title_full Active surveillance in intermediate risk prostate cancer: is it safe?
title_fullStr Active surveillance in intermediate risk prostate cancer: is it safe?
title_full_unstemmed Active surveillance in intermediate risk prostate cancer: is it safe?
title_short Active surveillance in intermediate risk prostate cancer: is it safe?
title_sort active surveillance in intermediate risk prostate cancer: is it safe?
topic Difference of Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920556/
https://www.ncbi.nlm.nih.gov/pubmed/27286102
http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.03.04
work_keys_str_mv AT krishnananthannishanth activesurveillanceinintermediateriskprostatecancerisitsafe
AT lawrentschuknathan activesurveillanceinintermediateriskprostatecancerisitsafe